H. Burris

发表

Pooled analysis of diarrhea events in patients with cancer treated with lapatinib

Suzanne F. Jones, M. Koehler, J. Crown, 2008, Breast Cancer Research and Treatment.

First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumors

G. Giaccone, P. Moore, R. Lechleider, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Oral granisetron for the prevention of acute late onset nausea and vomiting in patients treated with moderately emetogenic chemotherapy.

D. Gruben, K. Yocom, C. Friedman, 2000, The oncologist.

Efficacy and safety of oral granisetron versus oral prochlorperazine in preventing nausea and emesis in patients receiving moderately emetogenic chemotherapy.

P. Hesketh, J. Cohn, D. Fitts, 1996, The cancer journal from Scientific American.

Association of Convalescent Plasma Treatment with Reduced Mortality and Improved Clinical Trajectory in Patients Hospitalized with COVID-19 in the Community Setting

L. Sears, A. Junglen, C. Lemaistre, 2021, medRxiv.

Population Pharmacokinetics of Trastuzumab-DM1, a First-in-Class HER2 Antibody-Drug Conjugate Given Every 3 Weeks (q3w) and Weekly (qw) to Patients with HER2-Positive Metastatic Breast Cancer (MBC).

P. LoRusso, M. Beeram, S. Girish, 2009 .

A Phase (Ph) I/II Study of CR011-VcMMAE, an Antibody-Drug Conjugate, in Patients (Pts) with Locally Advanced or Metastatic Breast Cancer (MBC).

L. Hart, J. Bendell, P. Siegel, 2009 .

Breast cancer, locally advanced and metastatic

L. Holmberg, O. Nanni, S. Barni, 2012 .

Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer.

L B Sheiner, A Riva, P M Ravdin, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of gemcitabine and carboplatin, plus trastuzumab in HER2+ patients as first line therapy in metastatic breast cancer.

J. Hainsworth, D. Yardley, N. Peacock, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I and pharmacokinetic trial of weekly CPT-11.

G. Weiss, S. Hilsenbeck, H. Burris, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer.

J. Hainsworth, H. Burris, M. Thomas, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Abstract P6-18-07: Ribociclib + endocrine therapy in patients with hormone receptor-positive, HER2-negative advanced breast cancer presenting with visceral metastases: Subgroup analysis of phase III MONALEESA trials

F. Esteva, Y. Yap, T. Bachelot, 2019, Poster Session Abstracts.